CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

A Spanish biotech banks $87M to make differentiated ADCs

Positive
AI Analysis

Summary

Ona Therapeutics, a Barcelona-based biotech, raised $87M to develop next-generation antibody-drug conjugates (ADCs) for advanced breast and colorectal cancers.

Importance:5/10
Sentiment:
0.50
ADCfinancingoncologybreast cancercolorectal cancerSpain
Related Companies

Read the original article

Published by BioPharma Dive on June 4, 2026 7:00 AM

Read Original